Wellnex Life Limited
ASX: WNX
Strong brand-led revenue growth and improved margins position Wellnex for accelerated global expansion.
(Source: TradingView) 3-Month Performance Profile of WNX on a DTF compared to S&P/ASX 200 (XJO).
Wellnex Life closed FY25 with a notable revenue surge of ~40% YoY to $23.63 million, largely powered by the strength of its owned brand portfolio, with Pain Away
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
